L. Sainz Comas

ORCID: 0000-0001-9249-1983
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Rheumatoid Arthritis Research and Therapies
  • Spondyloarthritis Studies and Treatments
  • Systemic Sclerosis and Related Diseases
  • Systemic Lupus Erythematosus Research
  • Gout, Hyperuricemia, Uric Acid
  • Dermatological and COVID-19 studies
  • Chronic Lymphocytic Leukemia Research
  • Salivary Gland Disorders and Functions
  • Inflammatory Myopathies and Dermatomyositis
  • COVID-19 Clinical Research Studies
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Skin Diseases and Diabetes
  • Long-Term Effects of COVID-19
  • Venous Thromboembolism Diagnosis and Management
  • Salivary Gland Tumors Diagnosis and Treatment
  • Monoclonal and Polyclonal Antibodies Research
  • Autoimmune and Inflammatory Disorders Research
  • Pneumonia and Respiratory Infections
  • Liver Diseases and Immunity
  • Psoriasis: Treatment and Pathogenesis
  • Inflammation biomarkers and pathways
  • Hip disorders and treatments
  • IgG4-Related and Inflammatory Diseases
  • Osteoarthritis Treatment and Mechanisms
  • Diagnosis and Treatment of Venous Diseases

Children's Mercy Hospital
2024

Hospital de Sant Pau
2020-2024

Universitat Autònoma de Barcelona
2022-2024

Institut de Recerca Sant Pau
2024

Center for Rheumatology
2024

Hospital Universitari de Vic
2011

Objective To assess whether the retention rate of certolizumab pegol (CZP) was longer than that other tumour necrosis factor inhibitors (TNFi) based on baseline rheumatoid (RF) levels. Methods Longitudinal, retrospective and multicentre study including patients with RA who were treated any TNFi (monoclonal antibodies (mAB), etanercept (ETA) or CZP). Log-rank test Cox regressions conducted to evaluate in three groups according level RF, third quartile levels used as cut-off: <200 (<Q3)...

10.1136/rmdopen-2023-003975 article EN cc-by-nc RMD Open 2024-02-01

Abstract Objective To study subclinical inflammation in intercritical gout patients and its relation to the estimated size of monosodium urate crystal deposition cardiovascular risk factors. Methods We performed a secretome analysis quantification cytokine adipokine plasma levels [IL-1β, IL-18, IL-6, soluble IL-6 receptor (sIL-6R), TNF-α, C-X-C motif chemokine 5, RANTES (Regulated upon Activation, Normal T Cell Expressed Presumably Secreted), leptin, resistin adiponectin] analyse patients....

10.1093/rheumatology/keab335 article EN Lara D. Veeken 2021-04-09

Refractory arterial hypertension (RAH) is frequently associated to a non-dipping blood pressure (BP) pattern; this profile has been shown have worse clinical prognosis. It common practice that patients receive anti-hypertensive medication preferentially in the morning. Non-dipping could be related timing of drug administration. We analysed whether switching bedtime improve BP control non-dipper with RAH. Twenty-seven consecutive RAH and or riser pattern on ambulatory (ABP) monitoring were...

10.1093/ndt/gfr557 article EN Nephrology Dialysis Transplantation 2011-09-21

: Cryoglobulinemia (CG) is marked by abnormal immunoglobulins (Ig) in serum, precipitating at temperatures below 37 °C. Current classification categorizes CG into three subtypes (types I, II, and III) based on Ig clonality. The features distinguishing patients with their etiology remain unidentified. Aiming to characterize clinical serological profiles of individuals, we conducted an observational analysis a large cohort compared characteristics underlying causes: hepatovirus (HV)...

10.3390/jcm13206069 article EN Journal of Clinical Medicine 2024-10-11

Abstract Background Sarilumab, an IL-6 receptor antagonist, is a first-line biologic disease-modifying anti-rheumatic drug for rheumatoid arthritis. The identification of genetic biomarkers as predictors response to sarilumab could allow personalized treatment strategy improve clinical outcomes. Methods We conducted retrospective cohort study 62 patients treated with determine whether single-nucleotide polymorphisms (SNP) in the IL6R gene predict efficacy and toxicity responses. Six SNPs...

10.1186/s13075-023-03209-1 article EN cc-by Arthritis Research & Therapy 2023-11-24

Rheumatoid arthritis (RA) is a prevalent autoimmune disease characterized by chronic that may lead to irreversible joint damage and significant disability. Patients with RA are commonly treated Tocilizumab (TCZ), an IL-6 receptor (IL-6R) antagonist, but many patients refractorily respond this therapy. Identifying genetic biomarkers as predictors of TCZ response could be key providing personalized medicine strategy. We aimed evaluate whether functional single nucleotide polymorphisms (SNPs)...

10.3390/pharmaceutics14091942 article EN cc-by Pharmaceutics 2022-09-14

Introduction: We conducted a comprehensive comparative analysis of the Okazaki, Umehara, and American College Rheumatology/European League Against Rheumatism (ACR/EULAR) classification criteria for diagnosing immunoglobulin G4-related disease (IgG4-RD). Materials Methods: A retrospective study was in single tertiary hospital, using expert clinical judgment as gold standard. compared diagnostic accuracy ACR/EULAR cohort 41 patients with suspected IgG4-RD. assessed sensitivity, specificity,...

10.3390/diagnostics14222583 article EN cc-by Diagnostics 2024-11-17

Background: Currently, there are no biomarkers to predict respiratory worsening in patients with Coronavirus infectious disease, 2019 (COVID- 19) pneumonia. Objectives: We aimed determine the prognostic value of Krebs von de Lungen-6 circulating serum levels (sKL-6) predicting COVID- 19 evolving trends. Methods: prospectively analyzed clinical and laboratory characteristics 375 mild lung disease on admission. sKL-6 was obtained all at baseline compared among worsening. Results: 45.1%...

10.1136/annrheumdis-2021-eular.1359 article EN other-oa Annals of the Rheumatic Diseases 2021-05-19

Abstract Objective: To determine whether differences exist in antibiotic prescribing for respiratory infections pediatric urgent cares (PUCs) by patient race/ethnicity, insurance, and language. Design: Multi-center cohort study. Setting: Nine organizations (92 locations) from 22 states Washington, DC. Participants: Patients ages 6 months–18 years evaluated April 2022–April 2023, with acute viral infections, otitis media effusion (OME), (AOM), pharyngitis, community-acquired pneumonia (CAP),...

10.1017/ice.2024.196 article EN Infection Control and Hospital Epidemiology 2024-12-03

<h3>Background</h3> Idiopathic inflammatory myopathies (IIM) are a heterogeneous group of acquired muscle diseases, which have distinct clinical, pathological and histological features. Autoantibodies clinically useful biomarkers to help the diagnosis IIM. Raynaud's phenomenon is very frequent presence microvascular changes in IIM been described however, role nailfold videocapillaroscopy NVC) for prognosis not clearly established. <h3>Objectives</h3> The aim this study was relationship...

10.1136/annrheumdis-2023-eular.1196 article EN Annals of the Rheumatic Diseases 2023-05-30

Introduction This was an ambispective cohort study evaluating the prognostic significance of lymphocytic foci and its lymphoid composition in minor salivary gland biopsy (MSGB) for short-term disease flare severity Sjögren’s syndrome (SS). Methods The inclusion criteria comprised individuals meeting ACR/EULAR 2016 who underwent MSGB with infiltration more than 50 lymphocytes received clinical diagnosis between September 2017 December 2018. Patients inadequate samples were excluded. number...

10.3389/fimmu.2024.1332924 article EN cc-by Frontiers in Immunology 2024-02-26

Abstract Background/Aims Idiopathic inflammatory myopathies (IIM) are a heterogeneous group of acquired muscle diseases with distinct clinical, pathological and histological features. Interstitial lung disease (ILD) is frequent pulmonary manifestation in IIM (IIM-ILD) considerably influences morbidity mortality. Krebs von den Lungen 6 (sKL-6) has been proposed as potential biomarker reflecting the severity ILD connective tissue diseases. Raynaud’s phenomenon very presence microvascular...

10.1093/rheumatology/keae163.188 article EN Lara D. Veeken 2024-04-01

<h3>Background:</h3> Juvenile Idiopathic Arthritis (JIA) represents the most prevalent inflammatory rheumatic condition in childhood. Its heterogeneous nature presents challenges identifying feasible biomarkers for effective disease monitoring. Serum calprotectin (sCal) has emerged as a potentially valuable biomarker precisely assessing activity JIA. Despite various commercially available methods sCal determination, their usage remains limited and lacks validation. <h3>Objectives:</h3> To...

10.1136/annrheumdis-2024-eular.5617 article EN Annals of the Rheumatic Diseases 2024-06-01

<h3>Background:</h3> Interstitial lung disease (ILD) stands as the primary cause of mortality in patients with Systemic Sclerosis (SSc). Despite identification several risk factors to develop ILD SSc, limited research has been directed towards understanding their impact on progression established SSc-ILD. <h3>Objectives:</h3> This study aims evaluate clinical characteristics SSc and compare features between those experiencing progressive function decline without such progression....

10.1136/annrheumdis-2024-eular.5527 article EN Annals of the Rheumatic Diseases 2024-06-01

<h3>Background:</h3> Age, calcification and inflammatory burden may produce degenerative lesions in the aortic valve. It is described that root dilatation severe sclerosis of valve more frequently observed spondyloarthritis (SpA) patients compared to population without [1]. <h3>Objectives:</h3> Evaluate association between years disease evolution, age total time persistent inflammation as prognostic factors for Identify comorbidities associated with within context specified disease....

10.1136/annrheumdis-2024-eular.2321 article EN Annals of the Rheumatic Diseases 2024-06-01

Abstract Introduction Integrated care pathways (ICPs) are crucial for delivering individualised care. However, the development of ICPs is challenging and must be well designed to provide expected benefits. Regarding this, healthcare organisations increasingly adopting management systems based on Lean Thinking improve their organisational processes by eliminating non‐value‐added steps. This study elucidates process evaluates impact applying redesign an ICP patients with spondyloarthritis, a...

10.1111/jep.14132 article EN Journal of Evaluation in Clinical Practice 2024-09-10

Abstract Corresponding author: Amanda Nedved, MD, 6035 W 135th Street, Overland Park, KS 66223 785-243-6865 anedved@cmh.edu Funding Source: This work was supported by an investigator-initiated grant from Merck. Role of the Funder/Sponsor: The funder had no role in design and conduct study; collection, management, analysis, interpretation data; preparation, review, or approval manuscript; decision to submit manuscript for publication. Conflict Interest Disclosures: Dr. El Feghaly has research...

10.1093/jpids/piae088.003 article EN Journal of the Pediatric Infectious Diseases Society 2024-10-01

Tocilizumab is a first-line biologic disease-modifying anti-rheumatic drug (bDMARD) that inhibits the interleukin-6 (IL-6) pathway by antagonizing IL-6 receptor (IL-6R). widely used to treat rheumatoid arthritis (RA), prevalent autoimmune disease can cause irreversible joint damage and disability. Although many bDMARDs have been developed for RA, there lack of validated biomarkers which could guide personalized medicine strategies. To evaluate whether single-nucleotide polymorphisms (SNPs)...

10.3390/jpm13010061 article EN Journal of Personalized Medicine 2022-12-28

Background: Patients with autoimmune inflammatory rheumatic diseases (AIIRD) have a higher burden of infectious compared to the general population. This could be explained by disturbances in their immune system response, comorbidities and immunosuppressive treatment.Vaccination is most effective measure prevent infections. Objectives: To describe cohort patients AIIRD referred disease´s unit according vaccination protocol. Methods: Restrospective descriptive study 286 who were evaluated...

10.1136/annrheumdis-2021-eular.1801 article EN Annals of the Rheumatic Diseases 2021-05-19

<h3>Background</h3> The most important diagnostic test in Sjogren's syndrome is the minor salivary gland (MSGB). Immunohistochemical staining of MSGB may provide prognostic value for organ affection. <h3>Objectives</h3> To compare lymphocytic composition and major affection patients with during 3 years follow-up. worsening SSDDI index more than 2 points. <h3>Methods</h3> A retrospective cohort study was conducted. Inclusion criteria ≥18 that met 2016 ACR/EULAR Syndrome focal sialadenitis (≥1...

10.1136/annrheumdis-2023-eular.4116 article EN 2023-05-30

<h3>Background</h3> Little is known about the chronologic order of appearance extra-articular symptoms and spondylarthritis (SpA) its effect in disease progression. Most information based on population-based registries or big data that may lack precision. <h3>Objectives</h3> To describe duration, time until diagnosis articular (psoriasis, uveitis, inflammatory bowel disease) symptoms. evaluate factors associated with from onset SpA <h3>Methods</h3> A retrospective cohort study was conducted....

10.1136/annrheumdis-2023-eular.2124 article EN Annals of the Rheumatic Diseases 2023-05-30
Coming Soon ...